Clinical Trial Update: Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating solifenacin succinate for bladder symptoms caused by spinal cord injury or multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neurogenic Bladder
• Spinal Cord Injury

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Multiple Sclerosis, Neurogenic Bladder | Phase 4 | Status: COMPLETED